Path AI / coverage

360Dx article

Drug Discovery Trends article

Precision Oncology News eBlast

Additional coverage:

About

In February 2024, PathAI announced an exclusive collaboration with Roche Tissue Diagnostics to develop AI-enabled digital pathology algorithms for companion diagnostics. PathAI needed coverage that explained what the deal meant for diagnostics and drug development.

SVM secured and coordinated two interviews. Kelsy Ketchum of 360Dx wrote “With PathAI CDx Partnership, Roche Accelerates Digital Pathology Strategy,” and Brian Buntz of Drug Discovery Trends covered how PathAI and Roche are partnering on AI companion diagnostics.

The announcement also earned coverage in Precision Medicine Online (picked up in the Precision Oncology News email newsletter), Diagnostics World, CAP Today, Clinical Lab Products, HIT Consultant, Tissue Pathology, Drug Development & Delivery, and Discoveries in Health Policy.

Additional coverage: